Fig. 2From: Treatment resistant M-type phospholipase A2 receptor associated membranous nephropathy responds to obinutuzumab: a report of two casesClinical course, proteinuria, PLA2R antibody level and response in relation to anti-CD20 treatments in case 2. RTX, rituximab; PCR, protein creatinine ratio; PLA2R, phospholipase A2 receptorBack to article page